Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (101-110 of 241) with videos related to

Pageof 25
Sort By:
Blood|December 1, 1982
Cytotoxic T-cell clones derived from pluripotent stem cells (CFU-GEMM) of patients with Hodgkin's lymphomaA A Fauser, H A Neumann, K G Bross, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implicationJ Frisch, A Ganser, D Hoelzer, et al.
Bone Marrow Transplantation|March 1, 1997
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantationS Fetscher, M Lübbert, L Kanz, et al.
Anti-Cancer Drugs|September 7, 1999
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcomaC Kollmannsberger, W Brugger, J T Hartmann, et al.
Anti-Cancer Drugs|November 26, 1999
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancerJ T Hartmann, D Quietzsch, T Daikeler, et al.
Annals of Hematology|June 1, 1996
Assessment of the composition of bone marrow prior to and following autologous BMT and PBSCT by magnetic resonanceF Schick, H Einsele, B Weiss, et al.
Blood|December 3, 1998
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.
The British Journal of Radiology|April 29, 2008
Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parametersM Horger, P Pereira, C D Claussen, et al.
Cancer Research|March 4, 1998
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytesP Brossart, G Stuhler, T Flad, et al.
Transplantation|March 1, 1986
Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxinA A Fauser, L Kanz, P Casellas, et al.
Pageof 25

Showing results (101-110 of 241) with videos related to

Sort By:
Pageof 25
Blood|December 1, 1982
Cytotoxic T-cell clones derived from pluripotent stem cells (CFU-GEMM) of patients with Hodgkin's lymphomaA A Fauser, H A Neumann, K G Bross, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implicationJ Frisch, A Ganser, D Hoelzer, et al.
Bone Marrow Transplantation|March 1, 1997
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantationS Fetscher, M Lübbert, L Kanz, et al.
Anti-Cancer Drugs|September 7, 1999
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcomaC Kollmannsberger, W Brugger, J T Hartmann, et al.
Anti-Cancer Drugs|November 26, 1999
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancerJ T Hartmann, D Quietzsch, T Daikeler, et al.
Annals of Hematology|June 1, 1996
Assessment of the composition of bone marrow prior to and following autologous BMT and PBSCT by magnetic resonanceF Schick, H Einsele, B Weiss, et al.
Blood|December 3, 1998
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.
The British Journal of Radiology|April 29, 2008
Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parametersM Horger, P Pereira, C D Claussen, et al.
Cancer Research|March 4, 1998
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytesP Brossart, G Stuhler, T Flad, et al.
Transplantation|March 1, 1986
Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxinA A Fauser, L Kanz, P Casellas, et al.
Pageof 25